Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan-Kettering Cancer Center and other centers identified genetic mutations and pathways that distinctly set the disease apart not only from other types of ovarian cancer, but from other solid tumors as well. The findings, reported in the June 30 issue of Nature, may be useful in helping doctors to choose experimental treatments that are most likely to effectively target molecular alterations in patients with this type of ovari...

An Interview with Paul Sabbatini

From an early age, medical oncologist Paul Sabbatini has had a keen interest in analyzing symptoms and diagnosing problems. Now a specialist in treating gynecologic cancers, he leads a Memorial Sloan-Kettering Cancer Center clinical research program seeking to improve treatments for ovarian cancer by harnessing the power of the immune system.

Read full article in Center News>

Study Leads to New Recommendations for Surgical Treatment of Many Women with Breast Cancer

With all the progress made in cancer surgery over the past several decades, one practice has remained largely unchanged -- until now. For more than a century, women with breast cancer that has spread beyond the breast have been undergoing a potentially debilitating and painful procedure in which all the lymph nodes in the armpit are removed.

Read full article in Center News>